Reflex Cardiac Asystole

In this report we present the case of a patient with recurrent syucopal episodes. During one of the attacks the patient was monitoring by telemetry and the ECC lead showed asvstole for more than 7 seconds. As in cases of the carhlinhibitory type of hypersenstive carolid sinus svndrome [HCSS]. asvstole may represent suppression of the sinus node or suppression of both sinus and atioventricular [AV] node. Unfortunately, in contrast to HCSS, there is no maneuver that can reproducibly induce episodes of asystole. Consequentlty, very little is known about the occurrence of AV block in the presence of sinus arrest. In the patient described in this report. We were able to demonstrate that suppression of sinus and AV nodes occured simultaneously. This is interesting to note that in this type of syneope data from noninvasive and invasive techniques in assessing sinus nodal and AV nodal conduction may note be conclusive. In the group of patients with this type of syncope, permanent artial demand pacing is constraindicated.     

Programming a Long Paced Atrioventricular Interval May Be Risky in DDDR Pacing

In patients with intermittent AV block and dual chamber pacemakers, a long paced AV interval of 200 msec or more can be selected to prolong pulse generator life (by avoiding the ventricular pace output) and to enable a more physiological and hemodynamically superior activation sequence. This case report describes the potential risks of programming a long paced AV interval in a patient with a DDDR pacemaker. T wave pacing, as described here, can occur if the conducted QRS complex is not sensed because it occurs during the ventricular blanking period (delivery of the atrial stimulus). This can be initiated by the mechanisms that induce apparent and actual P wave undersensing of the conducted QRS complex. In this case report apparent P wave undersensing and subsequent T wave pacing with ventricular capture (in a patient with intermittent AV block) occurred frequently during an exercise test done in the DDDR mode with a paced AV interval of 200 msec, according to the clinical evaluation protocol.     

Heart Rhythm During Syncope and Presyncope: Results of Implantable Loop Recorders

NIEROP, P.R., et al. : Heart Rhythm During Syncope and Presyncope: Results of Implantable Loop Recorders. Ambulatory ECG monitoring in patients with recurrent syncope is nondiagnostic in the majority of cases. Recently, an ECG implantable loop recorder (ILR) has been introduced. The ILR performs continuous ECG monitoring over a period of at least 14 months. From February 1997 to September 1999, 35 patients underwent implantation of an ILR. During a mean follow-up of  11 ± 8 months  , 24 (69%) patients had recurrent syncope or presyncope events. Four (11%) patients were not capable of activating the ILR to save the event. A symptom-rhythm correlation could be studied in 20 (83%) of 24 patients. Forty of 44 recurrences were captured by the ILR. There were 14 (40%) patients with at least one syncopal episode. An arrhythmic cause for syncope was found in eight of them (bradycardia in four and tachycardia in four). In the other six patients the heart rhythm was normal. In 17 (49%) patients with 1-year follow-up, the mean syncope event rate 12 months before ILR implantation was  4.7 ± 2.4  , whereas the mean syncope event rate 12 months after ILR implantation was  1.3 ± 0.7  (  P < 0.01  ). Resolution of symptoms was observed in 6 (17%) patients. These patients were significantly younger than patients without resolution (  50 ± 18 vs 69 ± 14 years, p < 0.01  ) and five were women. Three (9%) patients died during follow-up, all of them were noncompliant during their follow-up. In conclusion, the ILR made symptom—rhythm correlation possible in 83% of patients with recurrent syncope. Syncope recurrences decreased significantly after implantation of the device, especially in the younger patients. Noncompliant patients had a high mortality rate.     

Failure to Sense P Waves During DDD Pacing

ECG tracings of three patients in whom AV universal (DDD) pacemakers were implanted intermittently demonstrated dropped P waves. In one patient, true atrial undersensing was present; in the others, sensing of the atrial electrode was appropriate, but sensing of sinus P waves was intermittently blocked by normal pacemaker operation. In this report we discuss the electrocardiographic diagnosis of atrial undersensing in order to avoid unnecessary reinterventions.     

Atrial Capture and Dual Chamber Pacing

During dual chamber pacing it is sometimes impossible to assess atrial capture even on the 12-lead ECG. We developed a strategy to identify atrial capture when it is not possible to do so by ECG, and when the ECG shows no evidence of spontaneous or paced atrial activity.     

Responses of an AV Universal (DDD) Pulse Generator (Cordis 233D) to Programmed Single Ventricular Extrastimuli

To evaluate factors playing a role in initiation and perpetuation of pacemaker-mediated tachycardias (PMTs), 22 consecutive patients with symptomatic conduction disorders were studied after implantation of an AV universal (DDD) pulse generator (Cordis 233D). Patients were divided into two groups, depending upon the presence or absence of ventriculo-atrial (VA) conduction during electrophysiological study (EPS) performed before pacemaker implantation. PMTs could be initiated in six of eight patients of Group I and in none of 14 patients of Group II. Initiation and perpetuation of PMTs during DDD pacing were dependent upon the capacity of the patient to conduct ventricular premature beats (VPBs) and subsequent paced ventricular beats retrogradely to the atria, and upon three programmable parameters of the pulse generator (AV delay period, upper rate limit, tachycardia response). Programmed single ventricular extrastimulation demonstrated that: (1) merely the presence of VA conduction during EPS, although necessary, was not sufficient to induce PMTs after DDD pacemaker implantation; (2) VPBs introduced late rather than early in the cardiac cycle initiated PMTs in a different way; (3) the initiation of PMTs could be prevented during study by adjusting the programmable parameters (AV delay period, upper rate limit, tachycardia response); (4) one of the two available tachycardia responses of the pulse generator (gradual fall-back response) was able to terminate and initiate PMTs consistently. These observations helped in understanding the responses of the Cordis 233D pulse generator to ventricular premature beats. They indicate that additional refinement of the pulse generator is necessary to solve the problem of PMT.     

Pacemaker Electrocardiography of Rate Smoothing During DDD Pacing

A rate smoothing option is available in a new bipolar AV universal (DDD) pacemaker. In three patients, two with intact retrograde conduction and one with retrograde block, rate smoothing values of 3% and 6% were programmed. Irregular pacemaker-mediated tachycardia occurred in one patient and AV synchrony was temporarily lost in the other two patients. In this report, we describe the pacemaker electrocardiography of rate smoothing during DDD pacing.     

Fentanyl-etomidate anesthesia for cardioversion

The effectiveness and safety of anesthesia with fentanyl andetomidate were evaluated in 44 patients undergoing electivecardioversion. No drop in blood pressure was observed; endotrachealintubation was never necessary, and ambu bag assisted ventilationwas needed in only five patients. Anesthesia was induced within7 min in all patients with a mean dose of0.9 mg of fentanyland 15.4 mg of etomidate. After cardioversion, naloxone 0.2mg intravenously was used to antagonize fentanyl; patients werefully awake on average 9 min after the last cardioversion discharge.Complete amnesia was observed in all patients, both 1 hour aftercardioversion and the next morning. For cardioversion, fentanyl-etomidate is as safe, more effectiveand less time-consuming than diazepam.     

Effects of atriopeptin III on renal function, regional blood flows and left ventricular function in conscious dogs in presence or absence of hypovolaemia

Abstract. The effects of atriopeptin III (AP III) on the left ventricular and renal functions were studied in thirteen chronically instrumented conscious dogs and compared to those of the solvent (saline). In the normovolaemic state, an AP III infusion (1 μg kg^-1 min^-1 i.v.) had no effects on heart rate, on mean arterial or left ventricular pressure, on (dP/dt) Max (2989±119 vs. 3007±155 mmHg s^-1; NS) or on the relaxation rate. The left ventricular endocardial and epicardial coronary blood flows (radioactive microspheres) and the renal flow in the outer cortex (707–683 ml (min^-1 100 g^-1); NS) or in the inner cortex (563–570; NS) were also insignificantly affected by AP III infusion. However, AP III increased urinary flow from 24±6 to 36±7 ml h^-1 (P<0·025) and the Na⁺ and Cl^- excretions by 92 and 98%, respectively, (P<0·025 and P<0·05 vs. saline group) without altering significantly K⁺, urea and creatinine eliminations. In the moderately hypovolaemic state (mean reduction in renal flow: outer cortex -15%; P<0·05, inner cortex -5%; NS), AP III infusion at two doses (1 and 3 μg kg^-1 min^-1) still had no effects on arterial pressure and on the indexes of left ventricular inotropic state and relaxation but in this setting, the diuretic effect of AP III became variable. Five dogs markedly increased their excretion of water, Na⁺ and Cl^- whereas no change was noted in the seven remaining dogs. Regional renal blood flows and urinary output before infusion were similar in the responders and non-responders but the mean arterial pressure (81±2 vs. 73±3 mmHg; P<0·01) was lower in the non-responders. It is concluded that AP III has no effect on left ventricular contractility or on the coronary vasculature; at small doses, its diuretic effects appear independent of a renal vasodilation and are rapidly blunted in the presence of hypotension.     

The A-R Interval as Exercise Indicator: A New Option for Rate Adaptation in Single and Dual Chamber Pacing

RUITER, J.H., ET AL.: The A-R Interval as Exercise Indicator: A New Option for Rate Adaptation in Single and Dual Chamber Pacing. We investigated the possibility to use the interval from an atrial stimulus to the Ventricular R wave [A-R interval) as an indicator of physical stress, in 16 patients with pacemakers implanted for severe atrial bradycardia but with intact AV conduction. The A-R interval was studied during incremental atrial pacing at rest and during exercise with a constant workload. In addition, the atrial pacing rate was kept constant just above spontaneous sinus rate and the dynamics of the A-R interval were studied during exercise with a low constant workload and during a maximal exercise test with increasing workload. Incremental atrial pacing prolonged the A-R interval and this response was blunted during exercise [p < 0.003). Atrial pacing at a constant rate and during a constant workload resulted in an almost direct shortening of the A-R interval. When the workload was increased but the atrial rate kept constant, a pronounced shortening of the A-R interval was noted [p < 0.0001). It is concluded that changes of the A-R interval during different kinds of exercise were prompt and predictable in patients with sinus node dysfunction but intact AV conduction. In these patients the shortening of the A-R interval during exercise may be a suitable indicator for rate adaptive atrial pacing.